{"denoms":[{"counts":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"65"}],"units":"Participants"}],"groups":[{"description":"Original dose of 40 mg oral reduced to 30mg and than lower dose of either 10 mg (Group 1) or 20 mg (Group 2) tablets once a day for 5 days in a row and repeated every 4-8 week cycle.","id":"BG000","title":"Oral Clofarabine"},{"description":"Arm A: 10 mg tablets once a day for 5 days in a row and repeated every 4-8 week cycle.","id":"BG001","title":"Randomized, Oral Clofarabine 10mg"},{"description":"Arm B: 20 mg tablets once a day for 5 days in a row and repeated every 4-8 week cycle.","id":"BG002","title":"Randomized, Oral Clofarabine 20mg"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"53","upperLimit":"86","value":"70.0"},{"groupId":"BG001","lowerLimit":"43","upperLimit":"87","value":"67.5"},{"groupId":"BG002","lowerLimit":"54","upperLimit":"84","value":"72.5"},{"groupId":"BG003","lowerLimit":"43","upperLimit":"87","value":"70.0"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"23"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"42"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"65"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}